Loading...
Synaptogenix, Inc.
SNPX•NASDAQ
Healthcare
Biotechnology
$7.85
$1.80(29.86%)
Synaptogenix, Inc. (SNPX) Financial Performance & Statements
Review Synaptogenix, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns to understand its financial health and growth.
Revenue Growth
0.00%
Operating Income Growth
18.08%
↑ 18.08%
Net Income Growth
-111.45%
↓ 111.45%
Operating Cash Flow Growth
5.59%
↑ 5.59%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-113.04%
↓ 113.04%
ROIC
-33.86%
↓ 33.86%
Synaptogenix, Inc. (SNPX) Financial Statements
Explore quarterly and annual reports including balance sheet, income statement, cash flow for Synaptogenix, Inc. stock.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 |
| Cost of Revenue | $0.00 | $1175.00 | $0.00 | $1317.00 |
| Gross Profit | $0.00 | $0.00 | $0.00 | -$1317.00 |
| Gross Profit Ratio | $0.00 | |||
| R&D Expenses | $60816.00 | $424508.00 | $222897.00 | $342068.00 |
| SG&A Expenses | $1.008M | $1.75M | $1.14M | $1.24M |
| Operating Expenses | $1.07M | $2.18M | $1.36M | $1.58M |
| Total Costs & Expenses | $0.00 | $2.18M | $1.36M | $1.58M |
| Interest Income | $182334.00 | $181301.00 | $300681.00 | $330508.00 |
| Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
| Depreciation & Amortization | $0.00 | $1175.00 | $1689.00 | $1317.00 |
| EBITDA | $0.00 | -$2.18M | -$1.36M | -$1.58M |
| EBITDA Ratio | ||||
| Operating Income | $0.00 | -$2.18M | -$1.36M | -$1.58M |
| Operating Income Ratio | ||||
| Other Income/Expenses (Net) | $0.00 | -$5.55M | -$4.38M | $307658.00 |
| Income Before Tax | $385169.00 | -$5.55M | -$5.74M | -$1.27M |
| Income Before Tax Ratio | ||||
| Income Tax Expense | $217333.00 | -$789.91B | $0.00 | $0.00 |
| Net Income | $167836.00 | -$5.55M | -$5.74M | -$1.27M |
| Net Income Ratio | ||||
| EPS | $0.12 | -$4.58 | -$4.58 | -$1.18 |
| Diluted EPS | $0.04 | -$4.58 | -$4.58 | -$1.18 |
| Weighted Avg Shares Outstanding | $1.39M | $1.23M | $1.25M | $1.07M |
| Weighted Avg Shares Outstanding (Diluted) | $1.39M | $1.23M | $1.32M | $1.21M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan